New Frontiers, Landmark Trials, and Evolving treatment Paradigms for MS-A Year 2010 and Beyond Best Practice Update for the Neurology and MS Specialist Bruce A. Cree, MD, PhD, MCR
The Emergence of Immunosuppressive Agents for MS: Safety, Efficacy, and Cautionary Notes-Patient Monitoring , Risks for Infection, and Mechanisms of Action Mark J. Tullman, MD
The Long Haul: Optimizing Long-Term Functional Status and Financial Outcomes in RRMS with Immunomodulation Therapy: What Do The Trials Teach US? Guy Buckle, MD, MPH
The Foundation Role of Neuroimaging in MS Rohit Bakshi, MD, FAAN
Interactive Question and Answer Session Faculty Panel
